Literature DB >> 10942818

Gene therapy approaches for modulating bone regeneration.

S R Winn1, Y Hu, C Sfeir, J O Hollinger.   

Abstract

Following injury, bone has the ability to regenerate itself to a form and function nearly indistinguishable from the pre-injury state. However, if the injury is beyond a critical limit, recovery will not occur without therapeutic interventions. Autografts and implants with banked bone continue as the treatments of choice, although each exhibits limitations and liabilities. Alternatives have included the utilization of bone-graft substitutes that may incorporate bone derivatives and soluble signaling molecules such as mitogens and morphogens. In addition, an evolving treatment modality, gene therapy, offers an exciting avenue for bone regeneration. This review presents some of the current concepts for developing a rational gene therapy approach in bone regeneration.

Mesh:

Substances:

Year:  2000        PMID: 10942818     DOI: 10.1016/s0169-409x(00)00057-0

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  18 in total

1.  Cell-based gene therapy for repair of critical size defects in the rat fibula.

Authors:  Zawaunyka W Lazard; Michael H Heggeness; John A Hipp; Corinne Sonnet; Angie S Fuentes; Rita P Nistal; Alan R Davis; Ronke M Olabisi; Jennifer L West; Elizabeth A Olmsted-Davis
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

Review 2.  Bone repair cells for craniofacial regeneration.

Authors:  G Pagni; D Kaigler; G Rasperini; G Avila-Ortiz; R Bartel; W V Giannobile
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

3.  Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair.

Authors:  Jian Li; Holger Jahr; Wei Zheng; Pei-Gen Ren
Journal:  J Vis Exp       Date:  2017-09-07       Impact factor: 1.355

4.  Gene therapy of bone morphogenetic protein for periodontal tissue engineering.

Authors:  Q M Jin; O Anusaksathien; S A Webb; R B Rutherford; W V Giannobile
Journal:  J Periodontol       Date:  2003-02       Impact factor: 6.993

5.  The effects of Runx2 immobilization on poly (epsilon-caprolactone) on osteoblast differentiation of bone marrow stromal cells in vitro.

Authors:  Ying Zhang; Xiaopei Deng; Erica L Scheller; Tae-Geon Kwon; Joerg Lahann; Renny T Franceschi; Paul H Krebsbach
Journal:  Biomaterials       Date:  2010-02-02       Impact factor: 12.479

6.  The small molecule phenamil induces osteoblast differentiation and mineralization.

Authors:  Kye Won Park; Hironori Waki; Woo-Kyun Kim; Brandon S J Davies; Stephen G Young; Farhad Parhami; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2009-05-11       Impact factor: 4.272

7.  Cbfa1/Runx2-deficiency delays bone wound healing and locally delivered Cbfa1/Runx2 promotes bone repair in animal models.

Authors:  Qisheng Tu; Jin Zhang; Laji James; Julia Dickson; Jean Tang; Pishan Yang; Jake Chen
Journal:  Wound Repair Regen       Date:  2007 May-Jun       Impact factor: 3.617

Review 8.  Biomaterials for Craniofacial Bone Regeneration.

Authors:  Greeshma Thrivikraman; Avathamsa Athirasala; Chelsea Twohig; Sunil Kumar Boda; Luiz E Bertassoni
Journal:  Dent Clin North Am       Date:  2017-10

9.  Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration.

Authors:  J T Koh; Z Zhao; Z Wang; I S Lewis; P H Krebsbach; R T Franceschi
Journal:  J Dent Res       Date:  2008-09       Impact factor: 6.116

10.  The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factor.

Authors:  Satheesh Elangovan; Sheetal R D'Mello; Liu Hong; Ryan D Ross; Chantal Allamargot; Deborah V Dawson; Clark M Stanford; Georgia K Johnson; D Rick Sumner; Aliasger K Salem
Journal:  Biomaterials       Date:  2013-10-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.